Nasal irrigation or nebulizing aerosol of isotonic or hypertonic saline is a traditional method for respiratory or nasal care. A recent small study in outpatients with COVID-19 without acute respiratory distress syndrome suggests substantial symptom resolution. We therefore analyzed pharmacological/pharmacodynamic effects of isotonic or hypertonic saline, relevant to SARS-CoV-2 infection and respiratory care.
Mixed search method.
Due to its wetting properties, saline achieves an improved spreading of alveolar lining fluid and has been shown to reduce bio-aerosols and viral load. Saline provides moisture to respiratory epithelia and gels mucus, promotes ciliary beating, and improves mucociliary clearance. Coronaviruses and SARS-CoV-2 damage ciliated epithelium in the nose and airways. Saline inhibits SARS-CoV-2 replication in Vero cells; possible interactions involve the viral ACE2-entry mechanism (chloride-dependent ACE2 configuration), furin and 3CLpro (inhibition by NaCl), and the sodium channel ENaC. Saline shifts myeloperoxidase activity in epithelial or phagocytic cells to produce hypochlorous acid. Clinically, nasal or respiratory airway care with saline reduces symptoms of seasonal coronaviruses and other common cold viruses. Its use as aerosol reduces hospitalization rates for bronchiolitis in children. Preliminary data suggest symptom reduction in symptomatic COVID-19 patients if saline is initiated within 48 h of symptom onset.
Saline interacts at various levels relevant to nasal or respiratory hygiene (nasal irrigation, gargling or aerosol). If used from the onset of common cold symptoms, it may represent a useful add-on to first-line interventions for COVID-19. Formal evaluation in mild COVID-19 is desirable as to establish efficacy and optimal treatment regimens.
The use of “Atemwegpflege” (care of the airways) or nasal care is a traditional German practice, as to provide moist to the airways and can be achieved by nasal sprays or inhalation of nebulized isotonic or hypertonic saline (Kochsalzlösung) [1,2,3,4,5,6,7,8]. This practice is being promoted by lung specialists, health care, and consumer organizations during COVID-19, whereby the use of nebulizing/aerosols with saline is recommended, either stating that, while it may not change the risk of infection, it helps to mitigate the first symptoms or claiming that it effectively can “dam” (thus reduce) virus infection (“Einfaches Inhalieren kann Tröpfcheninfektion effektiv eindämmern”) [2,3,4,5,6]. Recently, also the Deutsche Gesellschaft für Krankenhaushygiene (DGKH) has formulated gargling/rinse measures to contain SARS-CoV-2 transmission in household, nursing homes, and schools .
Whether nebulizing isotonic or hypertonic saline may help to alleviate shortage of breath is not known. Respiratory secretions due to COVID-19 infection may behave similarly as those of a severe bronchitis or bronchiolitis; cough can be dry, but secretions can be clear to mucopurulent, and thus need to be mobilized to be removed from the airways. Aerosol use was actively discouraged in Belgium, as it is believed to create more risks for viral transmission, according to the APB (official pharmacist organization in Belgium) and Sciensano reports [10,11,12]. Also the World Health Organization (WHO) discourages the use of aerosolizing procedures in general . This risk was also raised at some stage in Germany, because of the fear that this technique would generate bio-aerosol drops, which could promote virus spread. This concept however was contradicted by a positioning statement of the German pneumologists . A recent small study in outpatients with COVID-19 without acute respiratory distress syndrome (ARDS) suggests substantial symptom resolution with hypertonic saline [15, 16].
We therefore investigated the mechanisms by which saline nasal spray/irrigation or aerosol may limit SARS-CoV-2 infectivity and spread. In particular, we discuss the evidence from the literature about the effects of saline on bio-aerosol formation, mucus, alveolar lining fluid (ALF), ciliary beat and mucociliary clearance (MCC), the angiotensin-converting enzyme 2 (ACE2), the sodium channel (ENaC), viral replication (host protease furin, viral protein 3CLpro), and formation of hypochlorous acid (HOCl), for their interaction with SARS-CoV-2. The assessment is not meant to address a role of saline in severe COVID-19 ARDS. We also briefly reviewed relevant clinical data and formulate recommendations in support of isotonic or hypertonic saline as a simple rinse or aerosol for an early reassuring intervention for upper respiratory infection and COVID-19.
A mixed method approach was taken. At first, information on epidemiological data and treatments of COVID-19 was searched for on the local Internet, as available from the official national sites and as promoted by respectable health care-related organizations in German and Dutch to consumers. As this analysis revealed a common recommendation of use of saline in the frame of COVID-19 in Germany, first systematic searches on established relevant keywords related to saline were performed on PubMed. This was followed by broader searches on new aspects as research progressed and suggested potential other mechanisms of saline relevant to COVID-19. Publications that focused on chronic respiratory diseases were not retained, unless if relevant to discriminate effects from a pharmacodynamic, pathophysiological, or safety point of view. Similarly, the search for relevant clinical effects of oral, nasal, and respiratory hygiene with saline was limited to keywords related to acute upper respiratory tract infections, with or without COVID-19 (SARS-CoV-2). For the pathways followed and the keywords and restrictions used to handle the vast amount of publications on saline and NaCl on PubMed, see Supplement 1.
To note: in this paper, isotonic saline refers to 0.9% NaCl (also called physiologic serum), while hypertonic saline refers to concentrations of 2% and above (commonly 3–7% in experimental and clinical studies and formulation in the market). “Aerosol” refers to nebulizing iso- or hypertonic saline, using a mist-forming device for inhalation and humidification to clear the airways and to remove phlegm in viral respiratory infections. We use the term “bio-aerosol”, when referring to the micro-droplets, spontaneously produced during exhalation, such as during speaking, singing and coughing.
The effects of isotonic and/or hypertonic saline are summarized in Fig. 1. They include the wetting/gelling properties, effect on MCC and hydration, SARS-CoV-2 viral replication and underlying mechanisms, as well as effect on the formation of hypochlorous acid (HOCl).
Wetting effect on ALF spreading and bio-aerosol formation
Saline changes the physicochemical properties of ALF, mucus, and vesicles/bio-aerosols, thereby affecting the molecular behaviour of ionic and non-ionic surfactants, proteins, and phospholipids in particular. Collectively, these effects are referred to as “wetting properties” of NaCl [17, 18], underlying 2 relevant phenomena: (1) better ALF spreading and (2) suppression of bio-aerosol formation.
Surface tension is an important factor in alveolar wetting, the MCC and the phenomenon of capillarity. The alveolar cells produce surfactant that decreases the surface tension in the airways, so reducing the amount of energy required to expand the lungs. From a pathophysiological perspective, the role of pulmonary surfactant in wetting, re-spreading, and compressing the ALF to ultra-low surface tensions is a mechanism that is well-known from preterm children. Such infants might suffer from infant respiratory distress syndrome, characterized by a lack of lung surfactant, which is needed to reduce surface tension forces and is critical for normal lung inflation [19, 20]. Isotonic saline aerosol has been proven to remediate this problem by its wetting properties and to be lifesaving by improving airway compliance [19, 20]. Alveolar type II epithelial cells (AT2) promote the biosynthesis of lung surfactant. SARS-CoV-2 attacks the AT2 cells, causing defective functionality of these cells, which may cause exhaustion of pulmonary surfactant, raise the alveolar surface tension, and finally lead to alveolar collapse [21, 22]. Hence, the wetting properties of NaCl may provide a benefit in reducing surface tensions, thus improving airway compliance.
Airway surface liquid (ASL) or saliva droplets carrying the virus are believed to convert into a bio-aerosol infecting the environment and bystanders, and therefore, the use of aerosolizing procedures has been discouraged by several authorities [10,11,12,13]. Yet, one should not confound saline aerosol with viral bio-aerosols produced after harvesting from cell cultures, or with bio-aerosol-generating procedures in the hospital (for more information, see Supplement 2): to-date, independent reviews about bio-aerosol generating procedures did not find enhanced risks for transmission of SARS-CoV-2 with nebulizing saline aerosol. In the studies by Edwards [23,24,25] (Table 1), the delivery of isotonic saline aerosol, nebulized over 6 min, reduced the release of exhaled bio-aerosols from the lungs by an average of 72% (lasting up to 6 hours), an effect persisting over 6 h upon nebulizing 1.29% CaCl2 diluted in 0.9% NaCl. The highest effect was obtained in high bio-aerosol emitters [23, 26]. Aerosol administration of saline to the airways particularly diminished the exhalation of smaller particles that facial masks fail to filter out . The effect of 6 min of isotonic saline nebulization on bio-aerosols was furthermore studied in a simulated cough model, producing under bursts of air a bio-aerosol of mucus mimetic. Saline reduced the fine mucin mimetic aerosol, while increased the droplet size of the mucus mimetic (volume-averaged median size 320 nm) instantaneously to 1 μm, and further to 65 μm at 30 min and 30 μM at 60 min . Nebulizing aerosol in a swine model of influenza led to the inhibition of the viral airborne transmission . The setup of another study by Simonds et al., simultaneously using non-invasive ventilation, did however not allow to draw firm conclusions . The German positioning paper on COVID-19 by pneumologists acknowledges the relevance of this property of nebulized isotonic saline, concluding “Although nebulizers with nozzles increase the amount of aerosol in room air, they do not increase the risk of infection for medical staff. The inhalation of isotonic saline solution significantly reduces (bio)aerosol release from the lungs” .
Table 1 lists furthermore two studies that assessed the effect of nasal rinsing or gargling with saline on viral titres in nasal lavage. These show that saline may also reduce viral transmission via a direct rinse effect of the gargling or nasal rinse with saline [28, 29]: the data support that rinsing leads to considerable direct removal of virus from surface liquid.
From a mechanistic focus, it is proposed that isotonic saline changes the gelling properties of mucin and surface tension of the liquid film on the airway epithelium, leading to less droplet/phospholipid vesicle formation and, as such, to less release of exhaled bio-aerosols [14, 30]. While mucus droplets easily rehydrate after evaporation, their properties are changed by adding NaCl . The mucus is gelled to less and stronger gelled particles, which leads to significantly less droplet formation upon nebulization . This effect is unique to saline and is also observed in presence of other ions that have a more limited effect on aerosol reduction. The effect was also sustained in the presence of surfactants and polysaccharides (dextrans), although the particle count was slightly enhanced by the latter substances: it was moreover found that surface tension was not the determinant factor, but rather the conductivity and viscosity . In the mono-, bi-, or multilayer vesicle technology, saline has been shown to supress the vesicle formation, to induce aggregation of vesicles, and to lead to faster vesicle deposition on surface substrates: the ionic nature makes it more easily to be captured by the substrate layer, while vice versa, as a result, droplets are more difficult to detach from the resulting salt-integrating surface substrate [31, 32]. Saline thus leads to much less bio-aerosol while remaining droplets may average larger sizes, as was shown by Edwards [23,24,25]: this will affect deposition indirectly in 2 ways: (1) faster deposition of droplets following coughing in the vicinity of the spreader (due to higher gravity and inertia of the larger droplets) ; (2) faster deposition of incidentally inhaled droplets in the nose and upper airways, as they are too large to penetrate into the bronchioles and lungs . The bio-aerosol formation for airborne transport will thus become more difficult, as was evidenced by Edwards with saline aerosol in the swine model of influenza .
Moreover, not only the droplet size but also the enhanced ionic nature of the bio-aerosol, induced by NaCl wetting, may lead to easier capture /better filtration by filter material. It was shown that a fine NaCl bio-aerosol penetrates less deep in face mask material (FFP1 and N95) as compared with corn oil bio-aerosol . CE-standard criteria for professional face masks ask filter capacities based on testing with plain paraffin aerosol: as surfactants highly change paraffin aerosol properties , this may not fully estimate the behaviour of viral-loaded bio-aerosols consisting of enveloped virus or surfactant (phospholipid) vesicles. The fact that the wetting effects of NaCl on bio-aerosol behaviour persist in presence of surfactant  may thus be relevant to filtering out viral-loaded bio-aerosol. Salt-covered masks have recently been developed as to destroy more quickly coronavirus droplets when landing on the mask material .
At last, saline will also lead to fast shrinkage of droplets upon evaporation in the ambient air (already ongoing at a relative humidity of 90–95%): loss of water induces phase separation, enhanced salinity, and decreased pH in the droplets/particles, as well as re-organization of the phospholipids at the outer air-droplet interface [38, 39]. The hydrophobic nature of the resulting phospholipid-coat was found to impair rehydration of virus-loaded particles . Salt concentrations have been shown to adversely affect the survival of influenza virus in bio-aerosol , while increased hydrophobicity of the particles lead to faster and reduced deposition in the airways according to aerosol technology .
Role of saline in the MCC
The MCC is the major primary innate defence mechanism of the nose, airways, and lungs, continuously clearing these from dust, infectious, and other particles by the ciliary movements. Using different techniques, it has been shown that isotonic saline (aerosol or rinse) induces a positive effect on the ciliary beat frequency, reverses ciliostasis and promotes the MCC, both under physiological and damage-induced conditions [40,41,42,43,44]. Factors that play a role include the osmolality of the saline, the hydration of the ALF and the composition of the mucins.
Osmolality of saline. Pure water severely damages the normal human nasal epithelial cells, while isotonic saline (in contrast to hypo- and hypertonic saline) does not affect their morphology [45, 46]. Hypertonic saline has been shown to decrease the ciliary movement in human nasal epithelium [43, 47], while others report a faster MCC in healthy subjects, after-single dose nasal irrigation, or in the airways at 30 min, but not 4 h after inhalation (attributed to depletion of airway mucin) [44,45,46,47,48,49,50]. Hypertonic saline induces osmotic pressure, but has also been found to decrease the potential difference in nasal epithelia—a rapid, reversible, and dose-related effect indicating a direct effect of NaCl on ion transport across the human airway epithelium (not just attributable to a simultaneous change in osmolarity) . Hypertonic saline has also been found to affect the nasal epithelial permeability [52, 53]. Its use may be associated with nasal burning/irritation , while both hypo- and hypertonic saline aerosols may induce bronchoconstriction or cough, as observed in patients with asthma or moderate to severe chronic obstructive pulmonary disease [55,56,57,58].
Hydration of the ALF. The MCC requires coordination between the periciliary liquid near the cell surface and the overlaying transported mucus layer [59, 60]. Therefore, these layers need to be appropriately hydrated in the lungs and airways, allowing the cilia to beat properly, to move the mucus and to transport the trapped pathogens and particles. The nasal and respiratory mucin forms a gel layer, serving as a liquid reservoir for the periciliary layer . The height of the ALF or ASL and hydration of the periciliary liquid layer depend on opposing mechanisms in water transport: the outward chloride (Cl−) secretory transport through apical chloride channels (CFTR and CACC mediated), and the inward movement of water following active (re)absorption of Na+ through apical sodium channels ENaC. These ion transporting actions occur in concertation with the basolateral Na+/K+-ATPase, located in the ciliated cells [62,63,64]. Whereas several more ion transport processes are involved, Na+ and Cl− are the main drivers of the fluid movements. While the periciliary liquid layer normally contains NaCl in an amount below 50mM (< 0.29%), the upper layer of ASL would contain concentrations of these ions above 100mM: this gradient ensures effective and sustained transepithelial transport of ions and water, as well as effective ciliary beating . Saline thus contributes to the hydration status of the nasal and airway mucosa, while it also regulates the height of the ALF.
Mucus properties. The properties of the mucins affect the MCC as well. Healthy mucus is a gel with low viscosity and elasticity, easily transported by ciliary action . In contrast, pathologic mucus, such as produced during chronic pulmonary diseases or ARDS, has higher viscosity and elasticity: it is less easily cleared from the airways. Impaired mucus clearance induces cough, airway obstruction, and dyspnoea . In elderly patients in particular, there is often already stasis of thick, dehydrated mucus within the nasal cavities and nasopharynx, leading to postnasal drip, cough, and globus (pharyngeus) sensation . Decreased MCC may lead to persistent accumulation of mucus, so providing an environment for microbial growth of pathogens in the respiratory system and contributing to secondary infections and inflammation . Saline equilibrates in the mucus, which leads to several actions of NaCl on the mucus: better diffusibility of pathogens into the mucin ; enhanced entrapment in the gelled mucus (gelling observed at 100 mM (0.6%) NaCl [30, 68]); reduced adhesion of mucins to the epithelium (observed at 0.9% NaCl) ; enhanced ciliary transportability and clearance (already observed from 0.5% (90 mM) saline onwards) [61, 70]; and so easier coughing up and swallowing of mucins, better cough clearance, and relief of (chronic) cough [69, 71]. As saline aerosol helps to fluidize the mucins in the deeper airway layers, also mucin-attached pathogens involved in secondary pulmonary infections are more easily cleared . While most of these effects are obtained by isotonic or lower NaCl concentrations, highly dehydrated sputum and ASL, such as occurring in cystic fibrosis and chronic bronchopulmonary disease, require higher (hypertonic) saline concentrations, as to equilibrate the sputum for maximal transport by drawing additional water onto the ASL [71,71,73].
Saline thus contributes by different mechanisms to optimizing the MCC and to protect the airways against infection. This has been nicely illustrated in porcine ciliated airways: the viral yield of Influenza A virus in the ciliated epithelium was about two- to threefold higher 24 to 48-h post-infection in the case of ciliostasis, as compared to normal ciliary activity, while saline (up to 2%) led to full recovery of the ciliary activity and reversal of ciliostasis, thereby impeding the viral infection ; however, at NaCl concentration exceeding 2%, the recovery rate decreased the more the saline concentrations increased up to 11% NaCl hypertonicity . This further underlines the modulatory role of the salt concentration.
Noteworthy, additional factors might affect the MCC. Adding bronchodilators to saline aerosols, such as salbutamol or terbutaline, may improve the nasal MCC [74, 75]. In contrast, many preservatives, excipients, antimicrobial agents, lidocaine/ anaesthetics, opioids, and mucolytics, such as acetyl cysteine, decrease the MCC [74, 76].
Role of saline in mucosal hydration
The nasal cavity gets moistened as warm breath condensate, originating from the lungs, moves over the cooler nasal epithelial surface during expiration. Drying of the respiratory mucus and excessive dryness in the nose are common problems that have been associated with reduced ciliary function and decreased MCC [41, 77]. For instance, passage of dry cold air current or chilling depresses the mucous membrane temperature and ciliary movement, which manifests to a greater extent in the nasopharynx than in postnasal spaces . The speed of warming up of inhaled air depends on the respiratory frequency and volume of air inhaled, but hyperventilation leads to faster drying of the mucosa and reduced clearance from the lungs . Elderly people may more frequently suffer from a dehydrated mucosa, while they also show altered cilia, slower ciliary beating, changed properties of mucus and slower MCC [65, 78]. Nasal dryness is also affected by the body temperature, the temperature of the nose fluctuating directly with the core body temperature . Hence, also during high fever, there may be faster drying of the respiratory mucosa, making elderly patients with fever even more susceptible to viral aggression. Additionally, the prolonged use of facial masks is associated with dehydrated mucosa of the oronasal cavity . This is not surprising, as the conditioning mechanism, consisting of mucosal cooling during inhalation and condensation of the saturated, warm, exhaled air [77, 80], is drastically reduced.
As a consequence, humidification with saline aerosol may be beneficial. It is not known whether the hydration by saline occurs via promoting or restoring the ciliary function and/or other factors. It has been shown that “a fringe of ciliary activity persists” as long as there is sufficient moisture . However, if dryness of nasal epithelium lasted longer than 15–18 min in vitro, air humidification or water flushing of the epithelium could no longer restore the ciliary movement, while only isotonic saline or Ringer’s solutions did so . In line with these observations on ciliary movement, the process of mucosal hydration in surface airway epithelia was found not to be dependent on the cilia itself, but in the first place on the presence of soluble mediators in the ASL . The hydrating effects of saline (0.9–7.0%) have been well documented in chronic respiratory diseases that are associated with dehydrated mucins and reduced ASL in airways and/or lungs [72, 73, 82]. Yet, for a dry nose or larynx, isotonic saline is the concentration of choice to moisten the dry nasal mucosa [83, 84]. Health care professionals wearing well-fitting face masks report to suffer from less dryness in the nose and mouth if using isotonic saline nasal rinse/spray twice daily (morning/evening) . Mucosal hydration by saline may also play a role in dry cough: nasal isotonic saline has been found to reduce dry cough associated with acute respiratory illness, such as during flu or common cold .
Interactions of saline with SARS-CoV 2]
NaCl can directly affect SARS-CoV-2 virus infectivity by interacting with its ionic or electrostatic charges. NaCl is listed as an antimicrobial against coronaviruses MHV-2, MHV-N (mouse hepatitis viruses), and CCV (canine coronavirus), as these viruses lose infectivity after exposure to NaCl 0.23% . Machado et al. showed that the SARS-CoV-2 replication is dose-dependently inhibited by saline (0.8–1.7% NaCl) in Vero CL-81 cells . Inhibition of viral replication started from 0.6% onwards, increasing to 50% inhibition at 0.9% (isotonic) saline and reaching 100% at 1.5% (so mildly hypertonic) saline. Saline, however, had no direct effect on the SARS-CoV-2 itself: saline-pretreatment of the virus could not inhibit subsequent viral replication in the host cells. The authors proposed different underlying mechanisms: (1) NaCl-induced hyperosmotic stress leading to the SARS-CoV-2 inhibition (yet, unlikely, as no direct effect on the virus was shown), (2) decreased expression of the phosphokinase C signalling pathway (yet, this would require time for down-regulation), and (3) depolarization of the host cells via ENaC and its sodium sensor, the Nax channel, thereby over-stimulating ENaC and leading to electrolyte movements stressing the mitochondria (unlikely as rather ENaC dysregulation occurs—see below).
We identified five interactions of saline, relevant to viral tropism, that have been documented and thus are reachable, already at concentrations with isotonic saline:
Chloride- and pH-sensitive conformation of ACE2. ACE2 is the entry receptor of SARS-CoV-2 and is present in the nose, oropharynx, and airways (particularly in ciliated cells) [89,90,91]: increasing saline concentrations have been shown to induce dose-dependently immediate steric hindrance in the ACE-2 receptor configuration for binding of angiotensin (Ang) II: the inhibition starts at 100 mM (0.58%) NaCl which is close to a minimal effective inhibitory concentration of saline on SARS-CoV-2 replication (0.8% NaCl) [88, 92, 93]. Also relevant pH-mediated effects on binding of the endosomal ACE2 receptor have been reported for the first SARS-CoV virus: these effects would occur through interaction at a terminal glycosylation site, thereby inducing less virus-receptor binding .
Inhibition of the viral protease 3CLpro. Human coronaviruses, such as SARS-CoV and SARS-CoV-2, typically harbour and make use of 3CLpro, a chymotrypsin-like cysteine protease that regulates the viral replication machinery. There is no significant blocking effect up to 50 mM of NaCl on 3CLpro. However, higher concentrations (100 mM (~0.6%)) of NaCl does exhibit an almost full 3CLpro block, while the enzyme activity is also strongly pH dependent (fully blocked at pH<6.0) [95,96,97,98,99]. Significant inhibition and disruptive effects on the enzyme’s dimerization occur as NaCl concentrations move to values of >100 mM [96, 100, 101].
Inhibition of the host protease furin. TMPRSS2 and furin are involved in the proteolytic activation (priming) of SARS-CoV-2 spike protein [102,103,104]. The proteolytic activity of furin was previously found to be inhibited by NaCl, starting at 75 mM (~0.4%) onwards, and achieving > 90% inhibition at 100 mM (0.6%), and complete inhibition at 200 mM (~1.2%). No inhibitory effect was observed with KCl or CaCl2 solutions that rather stimulated furin . The inhibition is concordant with the finding of a furin insertion site by Anand et al that seems to be uniquely acquired by SARS-CoV-2 .
PH-shifts in nasal and airway environment. The pH of the incubation medium directly affects the unfolding of the SARS-CoV-2 spikes, which is hampered at pH 4.5 . A role of mild acidification in impeding SARS-CoV-2 replication is also suggested by the outcomes of in vitro studies in Vero-cells: complete inhibition of viral replication was observed with pure (unbuffered) saline (pH 5.5) and with NH4Cl (pH range 4.6–6.0), but not with phosphate buffered saline (PBS pH 7.4) [88, 107]. Both the pH and Na-concentration might be relevant to viral replications, similarly as suggested by the volume effects of added unbuffered saline, various sodium-containing buffers, and different pH levels as transport medium, observed with external polymerase on the detection levels of extraction-free SARS-CoV-2 RT-PCR of saliva samples . The pH of the nasal or airway surface liquid may be relevant to contracting the virus, the more as the healthy nose and airways, as well as sputum, have a slightly acidic pH (pH 5.5–6.5): this pH changes to more alkaline pH (pH 7.2–8.3) during common colds and chronic respiratory conditions . The mechanisms whereby saline acts acidic in vivo are complex and involve various channels in the respiratory epithelium [109, 110].
Interaction with ENaC. As already discussed, ENaC is the main mechanism for maintaining the height of ASL and regulating the ALF by stimulating the sodium absorption, so also preventing immersion and immobilization of the ciliated epithelium [62,63,64, 111]. Based on protein sequencing, Anand et al.  identified a S1/S2 cleavage site in SARS-CoV-2 that can mimic the proteolytic activation of human ENaC: the virus can hijack several proteases that are involved in the activation and regulation of ENaC (TMPRRSS2, furin, prostasin, and matriptase [113,114,115]), furin in particular in view of a unique furin insertion site in its S protein . Hence, this may lead to dysregulation of ENaC and the fluid balance in the lungs . Yet, fluid homeostasis is also regulated by the cooperation between ENaC and the sodium sensing Nax channel, directly activating ENaC [117, 118]. This mobilization and activation of ENaC via the Nax sensing channel activating ENaC is likely to take place with saline because the threshold for Nax activation in vitro is 150 mM (0.88%) extracellular Na+  and thus reachable with isotonic saline. In line with this mechanism, it was shown that iso- and hypertonic saline administered to an in vivo rat model was able to overcome pharmacological ENaC blockade of lung, leading to reabsorption of lung secretions .
Myeloperoxidase (MPO) activity
The interactions between NaCl and MPO are very complex, while those observed between SARS-CoV-2 and MPO so far have not been elucidated. The main actions of saline on MPO are discussed in Supplement 3. Basically, addition of NaCl to H2O2 producing cells in vitro will shift the MPO activity from peroxidation (to form H2O2) towards chlorination (to form HOCl). NaCl thus leads to the production of increased virucidal HOCl (bleach): this effect on MPO is already observed at 10 mM NaCl (0.058%), while the virucidal action of HOCl is observed at 0.09–1.7% NaCl [120, 121]. Moreover, whereas human MPO activity in neutrophils is active from 25 to 140 mM NaCl (0.14–0.82%) , the phagocytosis of pathogens requires continuous supply of chloride (Cl−) to sustain the HOCl generation in the phagosomes . Alternatively, because Cl− also competes with thiocyanate as a natural substrate for MPO activity, saline may shift the substrate thiocyanate towards antioxidant pathways, while its concomitant presence with thiocyanate increases the yield of virucidal hypothiocyanite formation . NaCl has also been shown to interact with reactive oxygen species production, as well as with extracellular neutrophil trap formation . These complex interactions are beyond the scope of this review but have received substantial attention in the context of (severe) COVID-19 [see Supplement 3]. The effects of NaCl on MPO may be clinically relevant in less severe presentations as well, as a pilot study using aerosols of electrolyzed saline (so containing HOCl) proved to be highly effective in the treatment and viral clearance of SARS-CoV-2 in ambulatory patients with COVID-19 .
Translation of the mechanisms into clinical benefits
Supplement 4 reviews the most relevant sources supporting the use of isotonic and hypertonic saline aerosol in (non-COVID-19) ARDS and bronchiolitis, as well the scarce data obtained so far in COVID-19 positive patients. In ARDS or bronchiolitis by other respiratory agents, such as the syncytial respiratory virus infection, aerosols of both isotonic and hypertonic saline have been shown to exert beneficial effects, such as improving respiration and the clinical severity scores, while hospitalization rate and/or duration were reduced, in particular in children (Table 2A, Supplement 4). Yet, overall, better outcomes were seen with isotonic as compared to hypertonic saline, in part because the latter was associated with worse cough in infants. In order to treat and prevent common cold and/or flu, studies support both acute and preventive use of saline irrigation (Table 2B, Supplement 4). The benefit of saline irrigation to promote recovery from common cold is acknowledged by the WHO [127, 128]. With regard to treatment of COVID-19 patients, limited pilot studies are available thus far. Two studies (one in upper respiratory tract infection caused by seasonal coronaviruses or common cold virus , one in symptomatic COVID-19 ) use a control group and support the early use of nasal and oral rinse with hypertonic saline, started within 48 h of symptom onset [15, 29]. Two observational studies are relevant from a safety perspective. A survey of COVID-19 patients with anosmia mentioned the use of saline by 57% of the patients: anosmia resolved over time but the recovery was not documented by initial treatment; to note is that none was hospitalized or developed ARDS . In a German study in patients with a more severe spectrum of illness, daily isotonic saline aerosol was used by 60 patients with COVID-19 ARDS. Administration was started prior to (bio-aerosol generating) non-invasive ventilation procedures: only 3 deteriorated and required intubation (all with severe comorbidity, of which one died); no health care workers got infected . For more details, we refer to Supplement 4.
In a majority of qPCR-positive persons, SARS-CoV-2 infection presents as asymptomatic or mild disease; yet, a minority of mainly older persons or patients with comorbidities or immune deficiency will develop severe ARDS. As COVID-19 ARDS is a serious complication, it requires early recognition and comprehensive management. Any preventive or acute treatment proposed for common cold—overlapping with COVID-19—should guarantee sufficient safety, if applied in an early stage. Since transmission may take place through bio-aerosol in the period prior to getting seriously symptomatic, effective hygiene measures, such as gargling or rinses, should be initiated as early as possible, as proposed by the DGKH. Treatment ideally should also be easy, safe, and at low cost. This analysis shows that saline rinse and aerosol are a safe and effective approach to treat and prevent upper respiratory tract infections and common colds, while the evidence presented in this manuscript also provides rational arguments for its application to contain and relieve mild COVID-19 infection, if started early within 48 h after the onset of symptoms. Although formal studies are welcome to address the optimal saline concentration(s) and frequency of applications, the data support the use of both isotonic and hypertonic saline, although for maintenance in the nose and/or lungs isotonic saline may be associated with less adverse events. Our recommendations based on this analysis are summarized in Table 3. These are in line with online recommendations to German consumers [1,2,3,4,5,6,7], and provide strong support for the gargling/rinse recommendations by the DGKH for use in the household, nursing homes, and school setting . Our analysis thereby substantiates several mechanisms, relevant to SARS-CoV-2 infection.
On one hand, saline provides advantages for preventive uses as a nasal spray or a rinse for the nose and oral cavity, because saliva has been implicated in transmission, while the unique physicochemical properties of saline lead to suppression of droplet formation [23,24,25,26]. If administered as a 0.9% saline aerosol for 6 min, the latter effect is the highest among superspreaders and leads to larger droplets that are more easily filtered by facial masks [23, 26]. This mechanism of action of saline was also shown to work experimentally in a swine model by preventing the airborne transmission of flu virus . Its aerosol use, add-on to the strong protective hygiene measures in the hospital during non-invasive ventilation in COVID-19-ARDS patients, was not associated with enhanced transmission . The findings are encouraging and invite to follow the recent recommendation of the DGKH to use gargling and nasal rinse with saline in a number of preventive situations, such as in care setting before meals or activities involving seniors or revalidating persons, family or professional reunions, church or religious gatherings (even if COVID-proof), or for kids in schools . Infected bio-aerosols are thought to be formed during coughing, or also during speaking or singing when bronchial secretions move over the vocal cords [131, 132], while bio-aerosols are insufficiently blocked by cotton and medical masks (even surgical or N95 and if well-fitting) . The unique wetting properties of NaCl identified in this study justify oronasal hygiene to be combined with the current face mask and distancing measures. In particular, maintenance of oronasal hygiene with saline (as aerosol, spray, or rinse) may achieve less penetration of the bio-aerosol through a mask . The finding that upon evaporation the enhanced salinity may deform virus-containing droplets  deserves further study, as to find out more on SARS-CoV-2 decay in NaCl/virus-loaded bio-aerosols.
On the other hand, many mechanisms of saline were identified that strengthen the innate primary defence mechanisms, such as promoting the MCC and interaction with MPO. These are complemented by various mechanisms inhibiting SARS-CoV-2 replication—all presenting at the saline concentrations currently in use (Table 2). Multiple mechanisms of action justify early use from the first onset of symptoms of COVID-19. Firstly, these mechanisms of NaCl may prevent massive viral replication and destruction of the cilia in the oral and nasal cavities—possibly by inhibiting the protease activity of furin and 3CLpro: SARS-CoV-2 targets ciliated cells in the nose and airways, releasing virus or abundant secretory vesicles, while also impairing the MCC [134,135,136]. The SARS-COV-2 spike protein also contains glycosides that effectively bind sialic acids (the main constituents of mucus) : as such, salt-induced gelling of mucus by the slightly acidic saline will improve viral clearance. As evidenced by Table 2, most in vitro pharmacological/pharmacodynamic effects of saline were achievable at concentrations reached by isotonic saline. This is reassuring from a pathophysiological point of view, since SARS-COV-2 mainly initiates infection in the nose and seeds by micro-aspiration to the lower airways, after which tracheal-produced virus would further seed via aspiration into the deep lung [136, 138]. Moreover, the reference values of Na+ and Cl− in the relevant fluids (saliva, nasal mucus and fluid (during common cold), periciliary liquid, ASL, ASL and sputum [139,140,141,142,143,144]) revealed to be generally lower than those in the mM NaCl concentration provided by isotonic saline (see Table 2B). As large volumes of saline can be safely repetitively used, this thus allows achieving relevant concentrations throughout the day to reach the described effects. Also safe long-term use is well documented in chronic lung disease. The analysis further suggests that due to its isotonic nature, saline may also help to reverse the bronchoconstriction in the case of hyper-secreted, thus potentially hypotonic ALF, as well as enhance cough clearance [17,18,19,20, 23, 30]. In view of the vast literature of saline, a limitation of this analysis though is that not all effects of saline or mechanisms relevant to SARS-CoV-2 may have been addressed.
To note, nasal and airway pH may be important in contracting COVID-19, in view of the observed pH-effects on protease and viral replication inhibition (Results Part 3). In addition, the pH affects the mucin binding by SARS-CoV-2, which was found to be absent if the mucins were buffered at pH 7.0 . Our recommendation is therefore to use pure saline (pH 5.5) for respiratory hygiene rather than buffered (seawater) sprays, although these may already work to some extent through the simple rinsing effect [86, 146]. Although often lukewarm or heated saline solutions are recommended for rinsing or inhaling, there is no evidence that this leads to better action of salt than the then the use of saline at room temperature . Other nasal spray compositions—with more or buffering ions, surfactants, emulsifiers, excipients, preservatives and/or active substances— may not necessarily lead to the same effects as identified in this analysis for pure saline, or may inhibit the ciliary beating [74,75,76]. Addition of certain surfactants to liquid formulations may enhance bio-aerosol formation [23, 30, 31] or be ciliotoxic (e.g. polyvidone-iodine ), while many (such as virucidal essential oils) may not respect the natural microbiome. Also the DGKH recommends saline formulations without additives, such as preservatives or decongestants . Similarly, trypsin–containing sprays claiming protection against COVID-19 based on a simple trypsin digest  are to be avoided, because the protease trypsin has been shown to rather enhance viral invasion and syncytia formation in appropriately designed host models [107, 150]; such sprays sold OTC as medical devices in the European Union are prohibited for sale in Germany because of lack of proof of efficacy.
We propose isotonic rather than hypertonic saline unless for gargling, where hypertonic 2% NaCl is recommended (also by the DGKH). Isotonic saline is devoid of the side effects that we identified throughout this analysis, such as changes in cell morphology and increased nasal epithelial permeability, nasal burning/irritation, and induction of bronchoconstriction or cough. Home-made saline (prepared with simple kitchen salt) is often proposed in the Internet (DGKH: tea spoon flat filled with table/kitchen salt (=2g/100mL corresponding to 1 soup spoon (20 g) in one litre of water). In line with the DGKH, usual applications for airway care are to be carried out 2 to 3 times a day, while ongoing clinical trials in symptomatic COVID-19 patients propose oronasal irrigation up to 12 times per day. Sterile sprays and uni-doses may be safer for nebulizing aerosol. Whether COVID-19 infection only requires (oro)nasal irrigation, or also inhalation of nebulized iso- or hypertonic saline, or whether it can add to other treatment strategies to limit transmission or damage of SARS-CoV-2 to the lungs, deserves further evaluation.
At last, some myths can be debunked. (1) Administration of saline as rinse or aerosol should not be confounded with transmission-prone aerosolizing procedures—a common misconception in respiratory care. Use of oxygen flow or invasive procedures causes the formation of virus-loaded bio-aerosols, by providing air over the infected surfactant-containing surface of the respiratory tract. Saline aerosol in contrast leads to suppression and reduction of exhaled bio-aerosol, as reviewed under Results (point 1). Obviously, saline aerosol and irrigation should be combined with the basic hygiene measures for COVID-19 (see Table 3), with use of disposable or washable tissues to collect superfluous rinse and mucus, with hand washing and adequate room ventilation. (2) Neither is there evidence that nasal rinse would lead to worsening olfaction. Nasal saline irrigation has no effect on normal olfaction , and its use in nasal disease has not led to adverse outcome . Its hydrating effect may possibly help to prevent and overcome dry nose during COVID-19 .
To summarize, despite the formal effects of saline should be studied in the future by use of (randomized controlled) trials, this review provides sufficient reasoning for the successful application and clinical relevance of saline in the context of mild and early COVID-19. Numerous actions of NaCl relevant to bio-aerosol reduction, primary defence mechanisms such as mucociliary clearance and HOCl production, and to containing SARS-CoV-2 infectivity were identified. These mechanisms are relevant as they are achievable at isotonic (or lower) and hypertonic saline concentrations, used for nasal rinse, respiratory hygiene (aerosol) and oral gargling. They may underlie the traditional use of saline for common cold.
acute respiratory distress syndrome
alveolar lining fluid
airway surface liquid
angiotensin converting enzyme
alveolar type 2 cells
HNO-Ärzte im Netz (2020) Herausgegeben vom Deutschen Berufsverband der Hals-Nasen-Ohrenärzte e.V.) Tipps zur richtigen Nasenpflege [Tipps for adequate nasal care]. https://www.hno-aerzte-im-netz.de/unsere-sinne/hno-hygiene/tipps-zur-richtigen-nasenpflege.html. Accessed 19 June 2020
Lungenartze im Netz (Lung doctors in the Net) (2020) Einfaches Inhalieren kann Tröpfcheninfektion effektiv eindämmern. [Simple inhalation can limit efficiently droplet infection] https://www.lungenaerzte-im-netz.de/news-archiv/meldung/article/einfaches-inhalieren-kann-troepfcheninfektion-effektiv-eindaemmern/. Accessed 19 June 2020
Praxisvita (das Portal für Gesundheit & Medizin) (2020) Inhalieren bei Corona: Wie wirksam ist das Hausmittel? [Inhalation during Corona; How effective is this home remedy?] https://www.praxisvita.de/coronavirus-dieses-hausmittel-hilft-bei-leichten-symptomen-18411.html . Accessed 19 June 2020
Leichter Atmen bei Lungen- und bronchialerkrankungen (2020) Corona: Pflege der Atemwege vermindert Infektionsrisiko [Corona: Care of the airways reduces the risk of infection]. [24.03.2020] https://www.leichter-atmen.de/copd-news/atemwegspflege. Accessed 19 June 2020
PARI-Blog (2020) Treatment and nebuliser therapy for COVID-19 in hospital. Interview with the Prof. Dr Kamin, Medical Director of the Hamm Lutheran Hospital. https://www.pari.com/int/blog/treatment-and-nebuliser-therapy-for-covid-19-in-hospital-interview-with-the-prof-dr-kamin-medical-director-of-the-hamm-lutheran-hospital/. Accessed in English 27 July 2020. - Firstly accessed in German: Accessed 19 June 2020
Betreut.de (2020) Coronavirus: Was Senioren & ihre Betreuer wissen müssen. [Coronavirus: What seniors and care givers need to know] www.betreut.be. Accessed 14 July 2020
ETH Zurich (2020) Mit Atemwegspflege das Infektionsrisiko senken. [With airway care decrease the risk of infection.] https://ethz.ch/de/news-und-veranstaltungen/eth-news/news/2020/03/zukunftsblog-viola-vogel-mit-atemwegspflege-das-infektionsrisiko-senken.html. Accessed 14 July 2020
Bronchiectasis Toolbox (2020) Hydration and humidification. https://bronchiectasis.com.au/physiotherapy/principles-of-airway-clearance/hydration-and-humidification. Accessed 13 July 2020
Kramer A, Eggers M, Hübner N-O et al (2020) Empfehlung der DGKH. Viruzides Gurgeln und viruzider Nasenspray [Virucidal gargling and virucidal Nose sprays]. Deutsche Gesellschaft für Krankenhaushygiene e.V., 01.12.2020. Accessed 9 January 2021. https://www.krankenhaushygiene.de/pdfdata/2020_12_02_Empfehlung-viruzides-gurgeln-nasenspray.pdf
Sciensano (2020) Consensus over het rationeel en correct gebruik van mondmaskers tijdens de COVID-19-pandemie [Consensus on the rational and correct use of mouth masks during the COVID-19 pandemic]. https://covid-19.sciensano.be/sites/default/files/Covid19/consensus%20on%20the%20use%20of%20masks_RMG_NL.pdf. Accessed 13 July 2020
Sciensano (2020) Procedure voor huisartsen in geval van een mogelijk geval van COVID-19. Versie 08 juli 2020. [Procedure for doctors in the event of a possible case of COVID-19]. https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_procedure_GP_NL.pdf . Accessed 13 July 2020
APB (2020) Aerosoltoestellen [Aerosol devices]. Information Update 20 March 2020. https://www.apb.be/APB%20Documents/NL/All%20partners/CORONAVIRUS_AEROSOL_VERHUUR_20_03_20.pdf. Accessed 19 June 2020
World Health Organization (2020) Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. Scientific Brief, 29 March 2020. https://www.who.int/publications-detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations. Accessed June 19, 2020.
Pfeifer M, Ewig S, Voshaar T et al (2020) Position paper for the state-of-the-art application of respiratory support in patients with COVID-19. Respiration 99:521–541. https://doi.org/10.1159/000509104
Kimura KS, Freeman MH, Wessinger BC et al (2020) Interim analysis of an open-label randomized controlled trial evaluating nasal irrigations in non-hospitalized patients with COVID-19. Int Forum Allergy Rhinol Sep 11 [Epub ahead of print]. https://doi.org/10.1002/alr.22703
ClinicalTrials.gov Identifier: NCT04347538. Impact of nasal saline irrigations on viral load in patients with COVID-19. https://clinicaltrials.gov/ct2/show/record/NCT04347538?term=saline&cond=covid-19&draw=2&rank=1
Santos FKG, Barros Neto EL, Moura TMCPA et al (2009) Molecular behavior of ionic and nonionic surfactants in saline medium. Colloids and Surfaces A: Physicochemical and Engineering Aspects 333:156–162. https://doi.org/10.1016/j.colsurfa.2008.09.040
Staszak K, WieczorekD MK (2015) Effect of sodium chloride on the surface and wetting properties of aqueous solutions of cocamidopropyl betaine. J Surfact Deterg 18:321–328. https://doi.org/10.1007/s11743-014-1644-8
Avery ME, Mead J (1959) Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Di Child 97(5_Part_I):517–5523. https://doi.org/10.1001/archpedi.1959.02070010519001
Ghadiali SN, Gaver DP (2008) Biomechanics of liquid-epithelium interactions in pulmonary airways. Respir Physiol Neurobiol 163(1-3):232-243. https://doi.org/10.1016/j.resp.2008.04.008
Huang J, Hume AJ, Abo KM et al (2020) SARS-CoV-2 infection of pluripotent stem cell-derived human lung alveolar type 2 cells elicits a rapid epithelial-intrinsic inflammatory response. bioRxiv [Preprint]:175695. https://doi.org/10.1101/2020.06.30.175695
Takano H (2020) Pulmonary surfactant itself must be a strong defender against SARS-CoV-2. Medical Hypotheses 144:110020. https://doi.org/10.1016/j.mehy.2020.110020
Edwards DA, Man JC, Brand P et al (2004) Inhaling to mitigate exhaled bioaerosols. Proc Natl Acad Sci USA 101(50):17383–17388. https://doi.org/10.1073/pnas.0408159101
Edwards DA, Fiegel J, DeHaan W et al (2006) Novel inhalants for control and protection against airborne infections. Resp Drug Delivery 1:41–48
Edwards D, Hickey A, Batycky R et al (2020) A new natural defense against airborne pathogens. QRB Discovery 1:e5. https://doi.org/10.1017/qrd.2020.9
Fiegel J, Clarke R, Edwards DA (2006) Airborne infectious disease and the suppression of pulmonary bioaerosols. Drug Discov Today 11(1-2):51–57. https://doi.org/10.1016/S1359-6446(05)03687-1
Simonds A, Hanak A, Chatwin M et al (2010) Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess 14:131–172. https://doi.org/10.3310/hta14460-02
Hendley JO, Gwaltney JM (2004) Viral titers in nasal lining fluid compared to viral titers in nasal washes during experimental rhinovirus infection. J Clin Virol 30(4):326–328. https://doi.org/10.1016/j.jcv.2004.02.011
Ramalingam S, Graham C, Dove J et al (2019) A pilot, open labelled randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold. Sci Rep 9:1015. https://doi.org/10.1038/s41598-018-37703
Watanabe W, Thomas M, Clarke R et al (2007) Why inhaling salt water changes what we exhale. J Colloid Interface Sci 307:71–78. https://doi.org/10.1016/j.jcis.2006.11.017
Patel A, Longmore N, Mohanan A, Ghosh S (2019) Salt and pH-induced attractive interactions on the rheology of food protein-stabilized nanoemulsions. CS Omega 4(7):11791–11800. https://doi.org/10.1021/acsomega.8b03360
Wang Q, Li W, Hu N et al (2017) Ion concentration effect (Na+ and Cl-) on lipid vesicle formation. Colloids Surf B Biointerfaces. 155:287–293. https://doi.org/10.1016/j.colsurfb.2017.04.030https://www.sciencedirect.com/science/article/abs/pii/S0927776517302163
Liu S, Novoselac A (2014) Transport of airborne particles from an unobstructed cough jet. Aerosol Sci Technol 48(11):1183–1194. https://doi.org/10.1080/02786826.2014.968655
Heyder J (2004) Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc 1:315–320. https://doi.org/10.1513/pats.200409-046TA
Rengasamy S, Zhuang Z, Niezgoda G et al (2018) A comparison of total inward leakage measured using sodium chloride (NaCl) and corn oil aerosol methods for air-purifying respirators. J Occup Environ Hyg 15(8):616–627. https://doi.org/10.1080/15459624.2018.1479064
Negm N (2008) Solubilization characteristics of paraffin oil in different types of surfactants. Egyptian J Chem 51(1):21–29 https://www.researchgate.net/publication/280015681_Solubilization_characteristics_of_paraffin_oil_in_different_types_of_surfactants
Baimes C (2020) Alberta researcher wins award for salt-coated mask innovation. The Canadian Press, CBC. https://www.cbc.ca/news/canada/edmonton/alberta-researcher-award-salt-masks-covid-1.5813921. Accessed 10 January 2021
Vejerano EP, Marr LC (2018) Physicochemical characteristics of evaporating respiratory fluid droplets. J R Soc Interface 15:20170939. https://doi.org/10.1098/rsif.2017.0939
Yang W, Elankumaran S, Marr LC (2012) Relationship between humidity and Influenza A viability in droplets and implications for influenza’s seasonality. PLoS ONE 7(10):e46789. https://doi.org/10.1371/journal.pone.0046789
Wolf G, Koidl B, Pelzmann B (1991) [Zur Regeneration des Zilienschlages humaner Flimmerzellen] Regeneration of the ciliary beat of human ciliated cells. Laryngorhinootologie 70(10):552–555. https://doi.org/10.1055/s-2007-998095
Daviskas E, Anderson SD, Gonda I et al (1996) Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur Respir J 9(4):725–732. https://doi.org/10.1183/09031936.96.09040725
Fu Y, Tong J, Meng F et al (2018) Ciliostasis of airway epithelial cells facilitates Influenza A virus infection. Vet Res 49(1):65. https://doi.org/10.1186/s13567-018-0568-0
Keojampa BK, Nguyen MH, Ryan MW (2004) Effects of buffered saline solution on nasal mucociliary clearance and nasal airway patency. Otolaryngol Head Neck Surg 131(5):679–682. https://doi.org/10.1016/j.otohns.2004.05.026
Sood N, Bennett WD, Zeman K et al (2003) Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects. Am J Respir Crit Care Med 167(2):158–163. https://doi.org/10.1164/rccm.200204-293OC
Kim C-H, Song MH, Ahn YE et al (2005) Effect of hypo-, iso- and hypertonic saline irrigation on secretory mucins and morphology of cultured human nasal epithelial cells. Acta Oto-Laryngologica 125:1296–1300. https://doi.org/10.1080/00016480510012381
Sumaily I, Alarifi I, Alsuwaidan R et al (2020) Impact of nasal irrigation with iodized table salt solution on mucociliary clearance: proof-of-concept randomized control trial. Am J Rhinol Allergy 34(2):276–279. https://doi.org/10.1177/1945892419892172
Min YG, Lee KS, Yun JB et al (2001) Hypertonic saline decreases ciliary movement in human nasal epithelium in vitro. Otolaryngol Head Neck Surg 124(3):313–316. https://doi.org/10.1067/mhn.2001.113145
Bencova A, Vidan J, Rozborilova E, Kocan I (2012) The impact of hypertonic saline inhalation on mucociliary clearance and nasal nitric oxide. J Physiol Pharmacol 63(3):309–313 http://www.jpp.krakow.pl/journal/archive/06_12/pdf/309_06_12_article.pdf
Talbot AR, Herr TM, Parsons DS (1997) Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope 107(4):500–503. https://doi.org/10.1097/00005537-199704000-00013
Bennett WD, Wu J, Fuller F et al (2015) Duration of action of hypertonic saline on mucociliary clearance in the normal lung. J Appl Physiol 118(12):1483–1490. https://doi.org/10.1152/japplphysiol.00404.2014
Middleton PG, Pollard KA, Wheatley JR (2001) Hypertonic saline alters ion transport across the human airway epithelium. Eur Resp J 17:195–199 https://erj.ersjournals.com/content/17/2/195
Jiao J, Yang J, Li J et al (2020) Hypertonic saline and seawater solutions damage sinonasal epithelial cell air-liquid interface cultures. Int Forum Allergy Rhinol 10(1):59–68. https://doi.org/10.1002/alr.22459
Miwa M, Matsunaga M, Nakajima N et al (2007) Hypertonic saline alters electrical barrier of the airway epithelium. Otolaryngol Head Neck Surg 136(1):62–66. https://doi.org/10.1016/j.otohns.2006.08.013
Hauptman G, Ryan MW (2007) The effect of saline solutions on nasal patency and mucociliary clearance in rhinosinusitis patients. Otolaryngol Head Neck Surg 137(5):815–821. https://doi.org/10.1016/j.otohns.2007.07.034
Balmes JR, Fine JM, Christian D et al (1988) Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols. Am Rev Respir Dis 138(1):35–39. https://doi.org/10.1164/ajrccm/138.1.35
Makker HK, Holgate ST (1993) The contribution of neurogenic reflexes to hypertonic saline-induced bronchoconstriction in asthma. J Allergy Clin Immunol 92:82–88. https://doi.org/10.1016/0091-6749(93)90041-d
Taube C, Holz O, Mücke M et al (2001) Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1810–1815. https://doi.org/10.1164/ajrccm.164.10.2104024
Lowry RH, Wood AM, Higenbottam TW (1988) Effects of pH and osmolarity on aerosol-induced cough in normal volunteers. Clin Sci (Lond) 74(4):373–376. https://doi.org/10.1042/cs0740373
Mandelberg A, Amirav I (2010) Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Paed Pulmonol 45:36–40. https://doi.org/10.1002/ppul.21185
Bartoszewski R, Matalon S, Collawn JF (2017) Ion channels of the lung and their role in disease pathogenesis. Am J Physiol Lung Cell Mol Physiol 313(5):L859–L872. https://doi.org/10.1152/ajplung.00285.2017
Fahy JV, Dickey BF (2010) Airway mucus function and dysfunction. N Engl J Med 2363(23):2233–2247. https://doi.org/10.1056/NEJMra0910061
Bustamante-Marin XM, Ostrowski LE (2017) Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol 9(4):a028241. https://doi.org/10.1101/cshperspect.a028241
Hollenhorst MI, Richter K, Fronius M (2011) Ion transport by pulmonary epithelia. J Biomed Biotechnol Article ID 174306, 16pages. https://doi.org/10.1155/2011/174306
Iwan IH, Dziembowska I, Słonina DA (2019) Airways surface liquid and ion Transport - The mechanism maintained patency. Biom J Scie Techn Res 14(3):1–7. https://doi.org/10.26717/BJSTR.2019.14.002543https://biomedres.us/fulltexts/BJSTR.MS.ID.002543.php
Pinto JM, Jeswani S (2010) Rhinitis in the geriatric population. Allergy Asthma Clin Immunol 6(1):10. https://doi.org/10.1186/1710-1492-6-10
Lillehoj EP, Kato K, Lu W, Kim KC (2013) Cellular and molecular biology of airway mucins. Int Rev Cell Mol Biol 303:139–202. https://doi.org/10.1016/B978-0-12-407697-6.00004-0
Lieleg O, Vladescu I, Ribbeck K (2010) Characterization of particle translocation through mucin hydrogels. Biophys J 98:1782–1789. https://doi.org/10.1016/j.bpj.2010.01.012
McCullagh CM, Jamieson AM, Blackwell J, Gupta R (1995) Viscoelastic properties of human tracheobronchial mucin in aqueous solution. Biopolymers 35(2):149–159. https://doi.org/10.1002/bip.360350203
Button B, Goodell HP, Atieh E et al (2018) Roles of mucus adhesion and cohesion in cough clearance. PNAS 115(49):12501–12506. https://doi.org/10.1073/pnas.1811787115
Wills PJ, Hall RL, Wm C, Cole PJ (1997) Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Inv 99(1):9–13 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC507760/pdf/990009.pdf
Lin L, Chen Z, Cao Y, Sun G (2017) Normal saline solution nasal-pharyngeal irrigation improves chronic cough associated with allergic rhinitis. Am J Rhinol Allergy 31(2):96–104. https://doi.org/10.2500/ajra.2017.31.4418
Elkins MR, Bye PT (2011) Mechanisms and applications of hypertonic saline. J R Soc Med 104(Suppl 1):S2–S5. https://doi.org/10.1258/jrsm.2011.s11101
Goralski JL, Wu D, Thelin WR et al (2018) The in vitro effect of nebulised hypertonic saline on human bronchial epithelium. Eur Respir J 51(5):1702652. https://doi.org/10.1183/13993003.02652-2017
Boon M, Jorissen M, Jaspers M et al (2016) The influence of nebulized drugs on nasal ciliary activity. J Aerosol Med Pulm Drug Deliv 29(4):378–385. https://doi.org/10.1089/jamp.2015.1229
Rusznak C, Devalia JL, Lozewicz S, Davies RJ (1994) The assessment of nasal mucociliary clearance and the effect of drugs. Respir Med 88(2):89–101. https://doi.org/10.1016/0954-6111(94)90020-5
Workman AD, Cohen NA (2014) The effect of drugs and other compounds on the ciliary beat frequency of human respiratory epithelium. Am J Rhinol Allergy 28(6):454–464. https://doi.org/10.2500/ajra.2014.28.4092
Rivera JA (1962) Cilia, ciliated epithelium, and ciliary activity. International Series of Monographs and Applied Biology. 1st edn. Pergamon Press ltd, Oxfor-London-NewYork-Paris pp.50-58. ISBN 978008009623
Paul P, Johnson P, Ramaswamy P et al (2013) The effect of ageing on nasal mucociliary clearance in women: a pilot study. Pulmonol Article ID 598589:5 pages. https://doi.org/10.1155/2013/598589
Purushothaman PK, Priyangha E, Vaidhyswaran R (2020) Effects of prolonged use of facemask on healthcare workers in tertiary care hospital during COVID-19 pandemic. Indian J Otolaryngol Head Neck Surg:1–7. https://doi.org/10.1007/s12070-020-02124-0
White DE, Bartley J, Nates RJ (2015) Model demonstrates functional purpose of the nasal cycle. BioMed Eng OnLine 14:38. https://doi.org/10.1186/s12938-015-0034-4
Tarran R, Trout L, Donaldson SH, Boucher RC (2006) Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia. J Gen Physiol 127(5):591–604. https://doi.org/10.1085/jgp.200509468
Hildenbrand T, Weber RK, Brehmer D (2011) Rhinitis sicca, dry nose and atrophic rhinitis: a review of the literature. Eur Arch Otorhinolaryngol 268(1):17–26. https://doi.org/10.1007/s00405-010-1391-z
Harvey PR, Tarran R, Garoff S, Myerburg MM (2011) Measurement of the airway surface liquid volume with simple light refraction microscopy. Am J Respir Cell Mol Biol 45(3):592–599. https://doi.org/10.1165/rcmb.2010-0484OC
Tanner K, Roy N, Merrill RM et al (2010) Nebulized isotonic saline versus water following a laryngeal desiccation challenge in classically trained sopranos. J Speech Language Hearing Res 53(6):1555–1566. https://doi.org/10.1044/1092-4388(2010/09-0249
Personal communications by pneumologists, dentists and paediatricians wearing daily well-fitting professional masks, July-October 2020
Slapak I, Skoupa J, Strnad P, Hornik P (2008) Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg 134:67–74. https://doi.org/10.1001/archoto.2007.19
Newster (2020) Eco-sustainable technology for the processing of healthcare waste (HCW), on-site or in centralized treatment centers. Coronaviruses: SARS, MERS and Covid19. 28/02/2020 http://www.newstergroup.com/news/coronaviruses__sars_mers_and_covid19
Machado RRG, Glaser T, Araujo DB et al (2020) Hypertonic saline solution inhibits SARS-CoV-2 in vitro assay. bioRxiv 2020.08.04:235549. https://doi.org/10.1101/2020.08.04.235549
Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052
Hou Y, Zhao J, Martin W et al (2020) New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med 18:art.No.216. https://doi.org/10.1186/s12916-020-01673-z
Sungnak W, Huang N, Bécavin C et al (2020) SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26:681–687. https://doi.org/10.1038/s41591-020-0868-6
Rushworth CA, Guy JL, Turner AJ (2008) Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis. FEBS J 275(23):6033–6042. https://doi.org/10.1111/j.1742-4658.2008.06733
Guy JL, Jackson RM, Acharya KR et al (2003) Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry 42(45):13185–13192. https://doi.org/10.1021/bi035268s
Vincent MJ, Bergeron E, Benjannet S et al (2005) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2:69. https://doi.org/10.1186/1743-422X-2-69
Chitranshi N, Gupta VK, Rajput R et al (2020) Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLpro targeting repurposed drug candidates. J Transl Med 18(1):278. https://doi.org/10.1186/s12967-020-02448-z
Graziano V, McGrath WJ, DeGruccio AM et al (2006) Enzymatic activity of the SARS coronavirus main proteinase dimer. FEBS letters 580(11):2577–2583. https://doi.org/10.1016/j.febslet.2006.04.004
Ferreira JC, Rabeh WM (2020) Biochemical and Biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro), from the novel coronavirus disease 19(COVID-19). Research Square. New York University Abu Dhabi, pp 1-17. https://assets.researchsquare.com/files/rs-40945/v1/e41c3648-96c7-4953-bb2b-a5c5d1a19e7f.pdf
Chang HP, Chou CY, Chang GG (2007) Reversible unfolding of the severe acute respiratory syndrome coronavirus main protease in guanidinium chloride. Biophys J 92(4):1374–1383. https://doi.org/10.1529/biophysj.106.091736
Abian O, Ortega-Alarcon D, Jimenez-Alesanco A et al (2020) Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int J Biol Macromol 164:1693–1703. https://doi.org/10.1016/j.ijbiomac.2020.07.235
Grum-Tokars V, Ratia K, Begaye A et al (2008) Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery. Virus Res 133(1):63–73. https://doi.org/10.1016/j.virusres.2007.02.015
Shi J, Song J (2006) The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain. The FEBS Journal 273(5):1035–1045. https://doi.org/10.1111/j.1742-4658.2006.05130.x
Bestle D, Heindl MR, Limburg H et al (2020) TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci Alliance 3(9):e202000786. https://doi.org/10.26508/lsa.202000786
Shang J, Wan Y, Luo C et al (2020) Cell entry mechanisms of SARS-CoV-2. PNAS 117(21):11727–11734. https://doi.org/10.1073/pnas.2003138117
Hasan A, Paray BA, Hussain A et al (2020) A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J Biomol Struct Dyn:1–9. https://doi.org/10.1080/07391102.2020.1754293https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189411/
Izidoro MA, Gouvea IE, Santos JA et al (2009) Lindberg I, Juliano L (2009) A study of human furin specificity using synthetic peptides derived from natural substrates, and effects of potassium ions. Arch Biochem Biophys 487(2):105–114. https://doi.org/10.1016/j.abb.2009.05.013
Zhou T, Tsybovsky Y, Olia AS et al (2020) A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike. bioRxiv [Preprint] 2020.07.04.187989 https://doi.org/10.1101/2020.07.04.187989
Ou X, Liu Y, Lei X et al (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11(1):1620. https://doi.org/10.1038/s41467-020-15562-9
Smyrlaki I, Ekman M, Lentini A et al (2020) Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR. Nat Commun 11:4812. https://doi.org/10.1038/s41467-020-18611-5
Fischer H, Widdicombe JH (2006) Mechanisms of acid and base secretion by the airway epithelium. J Membr Biol 211(3):139–150. https://doi.org/10.1007/s00232-006-0861-0
Reddi BA (2013) Why is saline so acidic (and does it really matter?). Int J Med Sci 10(6):747–750. https://doi.org/10.7150/ijms.5868
Enuka Y, Hanukoglu I, Edelheit O et al (2012) Epithelial sodium channels (ENaC) are uniformly distributed on motile cilia in the oviduct and the respiratory airways. Histochem Cell Biol 137(3):339–353. https://doi.org/10.1007/s00418-011-0904-1
Anand P, Puranik A, Aravamudan M et al (2020) SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. eLife 9:e58603. https://doi.org/10.7554/eLife.58603
Jaimes JA, Millet JK, Whittaker GR (2020) Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site. iScience 23:101212. https://doi.org/10.1016/j.isci.2020.101212
Ji HL, Zhao R, Matalon S, Matthay MA (2020) Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility. Physiol Rev 100(3):1065–1075. https://doi.org/10.1152/physrev.00013.2020
Kleyman TR, Carattino MD, Hughey RP (2009) ENaC at the cutting edge: regulation of epithelial sodium channels by proteases. J Biol Chem 284(31):20447–20451. https://doi.org/10.1074/jbc.R800083200
Szabó GT, Kiss A, Csanádi Z, Czuriga D (2020) Hypothetical dysfunction of the epithelial sodium channel may justify neurohumoral blockade in coronavirus disease 2019. ESC Heart Fail 17. https://doi.org/10.1002/ehf2.13078
Noda M, Hiyama TY (2015) The Nax Channel: What it is and what it does. The Neuroscientist 21(4):399–412. https://doi.org/10.1177/1073858414541009
Marunaka Y, Marunaka R, Sun H et al (2016) Na+ homeostasis by epithelial Na+ channel (ENaC) and Nax channel (Nax): cooperation of ENaC and Nax. ATM 4(Suppl 1):S11. https://doi.org/10.21037/atm.2016.10.42
Blé FX, Cannet C, Collingwood S et al (2010) ENaC-mediated effects assessed by MRI in a rat model of hypertonic saline-induced lung hydration. Br J Pharmacol 160(4):1008–1015. https://doi.org/10.1111/j.1476-5381.2010.00747.x
Ramalingam S, Cai B, Wong J et al (2018) Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels. Sci Rep 8:13630. https://doi.org/10.1038/s41598-018-31936-y
Zhang N, Francis KP, Prakash A, Ansaldi D (2013) Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles. Nat Med 19(4):500–505. https://doi.org/10.1038/nm.3110
Suzuki K, Yamada M, Akashi K, Fujikura T (1986) Similarity of kinetics of three types of myeloperoxidase from human leukocytes and four types from HL-60. Arch Biochem Biophysics 245(1):167–173. https://doi.org/10.1016/0003-9861(86)90201-8
Wang G, Nauseef WM (2015) Salt, chloride, bleach, and innate host defense. J Leukocyte Biol 98(2):163–172. https://doi.org/10.1189/jlb.4RU0315-109R
Chandler JD, Day BJ (2012) Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties. Biochem Pharmacol 84(11):1381–1387. https://doi.org/10.1016/j.bcp.2012.07.029
Nadesalingam A, Chen JHK, Farahvash A, Khan MA (2018) Hypertonic saline suppresses NADPH oxidase-dependent neutrophil extracellular trap formation and promotes apoptosis. Front Immunol 9:359. https://doi.org/10.3389/fimmu.2018.00359
Delgado-Enciso I, Paz-Garcia J, Barajas-Saucedo CE, Mokay-Ramírez KA Meza-Robles C, Lopez-Flores R (2020) Patient-reported health outcomes after treatment of COVID-19 with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care versus usual medical care alone: a randomized, open-label, controlled trial. Res Sq [Preprint] 10:rs.3.rs-68403. https://doi.org/10.21203/rs.3.rs-68403/v1
WHO (2020) Can rinsing your nose regularly with saline solution prevent Covid-19? https://www.who.int/docs/default-source/searo/thailand/12myths-final099bfbf976c54d5fa3407a65b6d9fa9d.pdf
Salmon Ceron D, Bartier S, Hautefort C et al (2020) APHP COVID-19 research collaboration. Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study. J Infect 81(4):614–620. https://doi.org/10.1016/j.jinf.2020.07.005
Voshaar T. COVID-19 Therapie aus Sicht eines Aerosol-Experten. PARI.de - Artzeportal 28 Juli 2020. https://www.pari.com/de/aerzteportal/news/covid-19-therapie-aus-sicht-eines-aerosol-experten Accessed 10 January 2021
Jayaweera M, Perera H, Gunawardana B, Manatunge J (2020) Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ Res 188:109819. https://doi.org/10.1016/j.envres.2020.109819
WHO (2020) Transmission of SARS-CoV-2: implications for infection prevention precautions. https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions Accessed 10 January 2021
Ueki H, Furusawa Y, Iwatsuki-Horimoto K et al (2020) Effectiveness of face masks in preventing airborne transmission of SARS-CoV-2. mSphere 5(5):e00637–e00620. https://doi.org/10.1128/mSphere.00637-20
Ehre C (2020) SARS-CoV-2 infection of airway cells. N Engl J Med 383:969. https://doi.org/10.1056/NEJMicm2023328
Zhu N, Wang W, Liu Z et al (2020) Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat Commun 11:3910. https://doi.org/10.1038/s41467-020-17796-z
Robinot R, Hubert M, Dias de Mehlo G et al (2020) SARS-CoV-2 infection damages airway motile cilia and impairs mucociliary clearance. bioRxiv. https://doi.org/10.1101/2020.10.06.328369
Baker AN, Richards SJ, Guy CS et al (2020) The SARS-COV-2 spike protein binds sialic acids and enables rapid detection in a lateral flow point of care diagnostic device. ACS Cent Sci 6(11):2046–2052. https://doi.org/10.1021/acscentsci.0c00855
Hou YJ, Okuda K, Edwards CE et al (2020) SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182(2):429–46.e14. https://doi.org/10.1016/j.cell.2020.05.042
Burke W (2014) The ionic composition of nasal fluid and its function. Health 06(08):720–728. https://doi.org/10.4236/health.2014.68093https://www.scirp.org/pdf/Health_2014032610554655.pdf
Grandjean Lapierre S, Phelippeau M, Hakimi C et al (2017) Cystic fibrosis respiratory tract salt concentration: an exploratory cohort study. Medicine 96(47):e8423. https://doi.org/10.1097/MD.0000000000008423
Kozlova I, Vanthanouvong V, Johannesson M, Roomans GM (2006) Composition of airway surface liquid determined by X-ray microanalysis. Ups J Med Sci 111(1):137-153. https://doi.org/10.3109/2000-1967-016https://www.tandfonline.com/doi/pdf/10.3109/2000-1967-016
Matsui H, Grubb BR, Tarran R et al (1998) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95(7):1005–1015. https://doi.org/10.1016/s0092-8674(00)81724-9
Wheatley CM, Cassuto NA, Foxx-Lupo WT et al (2010) Variability in measures of exhaled breath Na+, influence of pulmonary blood flow and salivary Na+. Clin Med Insights Circ Respir Pulm Med 4:25–34. https://doi.org/10.4137/ccrpm.s4718
Song Y, Thiagarajah J, Verkman AS (2003) Sodium and chloride concentrations, pH, and depth of airway surface liquid in distal airways. J Gen Physiol 122(5):511–519. https://doi.org/10.1085/jgp.200308866
Hao W, Ma B, Li Z et al (2020) Binding of the SARS-CoV-2 spike protein to glycans. bioRxiv. https://doi.org/10.1101/2020.05.17.100537
Bastier PL, Lechot A, Bordenave L et al (2015) Nasal irrigation: from empiricism to evidence-based medicine. A review. Eur Ann Otorhinolaryngol Head Neck Dis 132(5):281–285. https://doi.org/10.1016/j.anorl.2015.08.001
Nimsakul S, Ruxrungtham S, Chusakul S et al (2018) Does heating up saline for nasal irrigation improve mucociliary function in chronic rhinosinusitis? Am J Rhinol Allergy 32(2):106–111. https://doi.org/10.1177/1945892418762872
Niedner R (1997) Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents. Dermatology 195(Suppl2):89–92. https://doi.org/10.1159/000246038
Gudmundsdottir Á, Scheving R, Lindberg F, Stefansson B (2020) Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold. J Med Virol. https://doi.org/10.1002/jmv.26554.org/10.1002/jmv.26554
Kido H (2015) Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic options. Proc Jpn Acad Ser B Phys Biol Sci 91(8):351–368. https://doi.org/10.2183/pjab.91.351
Liu JJ, Chan GC, Hecht AS et al (2014) Nasal saline irrigation has no effect on normal olfaction: a prospective randomized trial. Int Forum Allergy Rhinol 4(1):39–42. https://doi.org/10.1002/alr.21235
Piromchai P, Puvatanond C, Kirtsreesakul V et al (2019) Effectiveness of nasal irrigation devices: a Thai multicentre survey. PeerJ 27(7):e7000. https://doi.org/10.7717/peerj.7000
Navarra J, Ruiz-Ceamanos A, Moreno JJ et al (2002) Acute nasal dryness in COVID-19. medRxiv 2020.11.18.20233874 [Preprint]. https://doi.org/10.1101/2020.11.18.20233874
Availability of data and material
Levi Hoste receives funding from the VIB Grand Challenges program.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: The correct presentation of the Author names are shown in this paper.
About this article
Cite this article
Huijghebaert, S., Hoste, L. & Vanham, G. Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19. Eur J Clin Pharmacol 77, 1275–1293 (2021). https://doi.org/10.1007/s00228-021-03102-3